Specific tandem duplications and fusions are important in detecting, prognostically scoring, and treating cancers (e.g. in AML, MLL PTDs[3]; FLT3 ITDs[4]; PML/RARA fusions[2]). The gene discussed is KMT2A; the disease is acute myeloid leukemia.